PT899267E - Novas trans-3,4,4a,5,6,10b-hexa-hidro-2h-naft(1,2b)-1,4-oxazinas di-substituidas processo para a sua preparacao e as composicoes farmaceuticas que as contem - Google Patents
Novas trans-3,4,4a,5,6,10b-hexa-hidro-2h-naft(1,2b)-1,4-oxazinas di-substituidas processo para a sua preparacao e as composicoes farmaceuticas que as contemInfo
- Publication number
- PT899267E PT899267E PT98402155T PT98402155T PT899267E PT 899267 E PT899267 E PT 899267E PT 98402155 T PT98402155 T PT 98402155T PT 98402155 T PT98402155 T PT 98402155T PT 899267 E PT899267 E PT 899267E
- Authority
- PT
- Portugal
- Prior art keywords
- substituted
- oxazins
- naft
- hexa
- hydro
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9710852A FR2767825A1 (fr) | 1997-09-01 | 1997-09-01 | Nouvelles trans-3,4,4a,5,6,10b-hexahydro-2h-napht°1,2-b!-1, 4-oxazines disubstituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT899267E true PT899267E (pt) | 2003-04-30 |
Family
ID=9510643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT98402155T PT899267E (pt) | 1997-09-01 | 1998-09-01 | Novas trans-3,4,4a,5,6,10b-hexa-hidro-2h-naft(1,2b)-1,4-oxazinas di-substituidas processo para a sua preparacao e as composicoes farmaceuticas que as contem |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6025356A (cg-RX-API-DMAC7.html) |
| EP (1) | EP0899267B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4417451B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN1088064C (cg-RX-API-DMAC7.html) |
| AT (1) | ATE229513T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU740928C (cg-RX-API-DMAC7.html) |
| BR (1) | BR9803933A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2246482C (cg-RX-API-DMAC7.html) |
| DE (1) | DE69810034T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK0899267T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2189108T3 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2767825A1 (cg-RX-API-DMAC7.html) |
| HU (1) | HU226059B1 (cg-RX-API-DMAC7.html) |
| NO (1) | NO311218B1 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ331637A (cg-RX-API-DMAC7.html) |
| PL (1) | PL194533B1 (cg-RX-API-DMAC7.html) |
| PT (1) | PT899267E (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA987963B (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0130219D0 (en) * | 2001-12-18 | 2002-02-06 | Pfizer Ltd | Compounds for the treatment of sexual dysfunction |
| EP1534679A4 (en) * | 2002-08-30 | 2007-06-06 | Biostratum Inc | INHIBITORS OF POST-AMADORI ADVANCED GLYCATION ENDPRODUCTS |
| JP2006523674A (ja) * | 2003-04-18 | 2006-10-19 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | 慢性閉塞性肺疾患（ｃｏｐｄ）のための組合せ治療法 |
| FR2906249B1 (fr) * | 2006-09-26 | 2008-12-19 | Servier Lab | Composes tetracycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| EP2098511A1 (en) | 2008-03-07 | 2009-09-09 | Solvias AG | Process for preparing compounds containing a hydronaphtalene structure with an unsymmetrically substituted benzene ring |
| WO2009156458A1 (en) * | 2008-06-27 | 2009-12-30 | H. Lundbeck A/S | Novel phenolic and catecholic amines and prodrugs thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1204745A (en) * | 1981-11-20 | 1986-05-20 | Merck Co. | Hexahydronaphth (1,2-b) -1,4 -oxazines |
| US4420480A (en) * | 1981-11-20 | 1983-12-13 | Merck & Co., Inc. | Hexahydronaphth[1,2-b]-1,4-oxazines |
| US4540691A (en) * | 1984-04-13 | 1985-09-10 | Nelson Research & Development Co. | Dopamine agonists and use thereof |
| US5486611A (en) * | 1989-07-13 | 1996-01-23 | The Upjohn Company | Carboxamido-(1,2N)-carbocyclic-2-aminotetralin derivatives |
| CA2083146A1 (en) * | 1990-06-15 | 1991-12-16 | Gevork Minaskanian | Substituted naphthoxazines useful as dopaminergics |
-
1997
- 1997-09-01 FR FR9710852A patent/FR2767825A1/fr active Pending
-
1998
- 1998-08-31 BR BR9803933-4A patent/BR9803933A/pt not_active Application Discontinuation
- 1998-08-31 NO NO19984007A patent/NO311218B1/no not_active IP Right Cessation
- 1998-08-31 US US09/144,025 patent/US6025356A/en not_active Expired - Lifetime
- 1998-08-31 PL PL328285A patent/PL194533B1/pl not_active IP Right Cessation
- 1998-08-31 HU HU9801951A patent/HU226059B1/hu not_active IP Right Cessation
- 1998-08-31 NZ NZ331637A patent/NZ331637A/xx not_active IP Right Cessation
- 1998-08-31 CA CA002246482A patent/CA2246482C/fr not_active Expired - Fee Related
- 1998-08-31 CN CN98119987A patent/CN1088064C/zh not_active Expired - Fee Related
- 1998-09-01 EP EP98402155A patent/EP0899267B1/fr not_active Expired - Lifetime
- 1998-09-01 JP JP24691098A patent/JP4417451B2/ja not_active Expired - Fee Related
- 1998-09-01 DE DE69810034T patent/DE69810034T2/de not_active Expired - Lifetime
- 1998-09-01 PT PT98402155T patent/PT899267E/pt unknown
- 1998-09-01 AU AU83024/98A patent/AU740928C/en not_active Ceased
- 1998-09-01 ZA ZA987963A patent/ZA987963B/xx unknown
- 1998-09-01 DK DK98402155T patent/DK0899267T3/da active
- 1998-09-01 ES ES98402155T patent/ES2189108T3/es not_active Expired - Lifetime
- 1998-09-01 AT AT98402155T patent/ATE229513T1/de active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2189108T3 (es) | 2003-07-01 |
| HU9801951D0 (en) | 1998-11-30 |
| DE69810034T2 (de) | 2003-08-14 |
| HK1020340A1 (en) | 2000-04-14 |
| PL194533B1 (pl) | 2007-06-29 |
| HUP9801951A2 (hu) | 2000-02-28 |
| FR2767825A1 (fr) | 1999-03-05 |
| HUP9801951A3 (en) | 2000-04-28 |
| CN1222516A (zh) | 1999-07-14 |
| JP4417451B2 (ja) | 2010-02-17 |
| CN1088064C (zh) | 2002-07-24 |
| HU226059B1 (en) | 2008-04-28 |
| DK0899267T3 (da) | 2003-03-10 |
| NO984007L (no) | 1999-03-02 |
| PL328285A1 (en) | 1999-03-15 |
| JPH11130759A (ja) | 1999-05-18 |
| CA2246482A1 (fr) | 1999-03-01 |
| AU8302498A (en) | 1999-03-11 |
| EP0899267B1 (fr) | 2002-12-11 |
| BR9803933A (pt) | 2001-04-24 |
| NO311218B1 (no) | 2001-10-29 |
| NO984007D0 (no) | 1998-08-31 |
| ATE229513T1 (de) | 2002-12-15 |
| AU740928B2 (en) | 2001-11-15 |
| ZA987963B (en) | 1999-03-04 |
| CA2246482C (fr) | 2002-11-26 |
| NZ331637A (en) | 1999-07-29 |
| US6025356A (en) | 2000-02-15 |
| DE69810034D1 (de) | 2003-01-23 |
| AU740928C (en) | 2002-05-16 |
| EP0899267A1 (fr) | 1999-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9600278D0 (en) | Remedy for nervous diseases | |
| BR9703447A (pt) | Novos compostos 3-(piperid-4-il)-1,2-benzisoxazol e 3-(piperazin-4-il) 1,2-benzisoxazol processos para a preparação dos mesmos e composições farmacêuticas contendo os mesmo | |
| PT97710A (pt) | Processo para a preparacao de novos derivados da amino-piperidina,da amino-pirrolidina e de amino-per-hidroazepina | |
| HUP0000610A2 (hu) | Fájdalomcsillapító hatású piperidinszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények | |
| PT95281A (pt) | Processo para a preparacao de derivados de 4-benzoil-isoxazol e de composicoes herbicidas que os contem | |
| ES2092580T3 (es) | Derivado de 2-ariltiazol y composicion farmaceutica que contiene el mismo. | |
| PT96361A (pt) | Processo para a preparacao de derivados de piridazinaminas e de composicoes farmaceuticas que os contem | |
| AR024390A1 (es) | Nuevos compuestos | |
| BR8901097A (pt) | Processo para a preparacao de uma composicao biocida | |
| DK0769296T3 (da) | Anvendelse af et natrium- eller lysiniumsalt af crotonsyreamidderivater til fremstilling af et lægemiddel til behandling af cancer | |
| AU740928C (en) | New disubstituted trans-3,4,4a,5,6,10b-hexahydro-2H-naphth (1,2-b)-1,4-oxazines, a process for their preparation and pharmaceutical compositions containing them | |
| BR9703367A (pt) | Emprego de antagonista da bradicina não-peptidicos para o tratamento e a prevenção de doenças do figado fibrogenéticos crônicas doenças do figado agudas e as complicações ligadas com as mesmas | |
| KR900018091A (ko) | 진경제 | |
| AU5473596A (en) | New indole, indazole benzisoxazole compounds, their process of preparation and the pharmaceutical compositions which contain them | |
| FI956016A0 (fi) | 1,2-silloitettujen 1,4-dihydropyridiinien käyttö lääkeaineina | |
| NO972943L (no) | 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende dem og deres anvendelse | |
| PT96564A (pt) | Processo para a preparacao de um novo antibiotico, desoximulundocandina, e de composicoes farmaceuticas que o contem | |
| ES2065192T3 (es) | Nuevos nicotinatos de diacil-glicerol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| NO964672L (no) | Nye tetracykliske 1,4-oksazinforbindelser, fremgangsmåter ved deres fremstilling og farmasöytiske sammensetninger innholdende dem | |
| PT816359E (pt) | 4-amino-2-ureido-pirimidina-5-carboxamidas, processo para a sua preparacao, medicamentos que contem estes compostos e sua utilizacao | |
| BR9801386A (pt) | Novos compostos de 6,7,8,9 - tetraidro-ciclopenta(a) naftaleno e de 2,3-didro-coclopenta(e) indeno processo para preparação dos mesmos e composições farmacêuticas contendo os mesmos | |
| PT92668A (pt) | Processo para a preparacao de derivados de azabiciclo-heptano | |
| DK0673934T3 (da) | Aminoalkylbenzothiazolinoner, fremgangsmåde til fremstilling af sådanne forbindelser og farmaceutiske sammensætninger indeholdende disse | |
| PT768307E (pt) | Aminas heterociclicas terrciarias processo para a sua preparacao e as composicoes farmaceuticas que as contem | |
| KR900004692A (ko) | 살균제 피리딜아미드 및 세균제어방법 |